검색어 : 통합검색[338.1]
총 4,033건 중 1,000건 출력
, 9/100 페이지
-
81
- 338 Serotonin-induced desensitization of the serotonin-1A receptor expressed in rat glioma C6BU-1 cells
- Saitoh, K.; Mikuni, M.; Ikeda, M.; Tomita, U.; Yamazaki, C.; Takahashi, K.; ; (Neuroscience research, Supplement, v.18, 1993, pp.S49)
-
82
- 338. 跳躍技における踏切り動作の研究 : (1) 走高跳の踏切りについて
- ; ; (Taiikugaku kenkyu (Japan Journal of Physical Education, Health and Sport Sciences), v.13, 1969, pp.169)
-
83
- Hsa_circ_0005909 promotes cell proliferation of osteosarcoma cells by targeting miR-338-3p/HMGA1 axis
- Zhang Cailong; Na Na; Liu Li; Qiu Yingzhu; The Affiliated Hospital of Qingdao University; Qingdao Eighth People' s Hospital; Qingdao Central Hospital; Zibo Central Hospital; (, v., 2020, )
-
84
- LncRNA SNHG15 acts as an oncogene in prostate cancer by regulating miR-338-3p/FKBP1A axis
- Zhang, Yuelong; Zhang, Dahong; Lv, Jia; Wang, Shuai; Zhang, Qi; Corresponding author.; (Gene, v.705, 2019, pp.44-50)
-
85
- R. Maury. L'intégration européenne. Paris, Recueil Sirey, 1958, 338 p., 1.800 FF.
- ; ; (Bulletin de l'Institut de recherches économiques et sociales, v.25, 1959, pp.639-639)
-
86
- 338 (PB326): Small-molecule bifunctional inhibitors of PARP1/2 and HDAC enzymes
- Truong, S.; Ramos, L.; Zhai, B.; Marzban, M.; Ghaidi, F.; Chen, X.; Langlands, J.; Brown, D.; Bacha, J.; Shen, W.; Daugaard, M.; ; (European journal of cancer, v.211, 2024, pp.114851)
-
87
- P1-338 Factors predicting the treatment response to cholinesterase inhibitors in Alzheimer's dementia
- Lucchi, Elena; Minicuci, Nadia; Magnifico, Francesca; Calza, Attilio; Avanzi, Stefano; Villani, Daniele; Bellelli, Giuseppe; Trabucchi, Marco; ; (Neurobiology of aging, v.25, 2004, pp.S194-S194)
-
88
- Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer
- Zhang, Fangbin; Yan, Yan; Cao, Xinguang; Zhang, Jinping; Li, Yingxia; Guo, Changqing; Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P. R. China; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P. R. China; Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P. R. China; Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P. R. China; Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P. R. China; Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P. R. China; (Aging, v.13, 2021, pp.12224-12238)
-
89
- circRAE1 promotes colorectal cancer cell migration and invasion by modulating miR-338-3p/TYRO3 axis
- Du Jiabin; Xu Jianhua; Chen Junxing; Liu Weinan; Wang Pengcheng; Ye kai; Second Affiliated Hospital of Fujian Medical University; Second Affiliated Hospital of Fujian Medical University; Second Affiliated Hospital of Fujian Medical University; Second Affiliated Hospital of Fujian Medical University; Second Affiliated Hospital of Fujian Medical University; Second Affiliated Hospital of Fujian Medical University; (, v., 2020, )
-
90
- Drug–drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338
- Furuta, Shigeru; Kamada, Emiko; Omata, Takeshi; Sugimoto, Tohru; Kawabata, Yoshihiro; Yonezawa, Keiko; Wu, Xiaochun Cheryl; Kurimoto, Tadashi; Central Research Laboratories, ZERIA Pharmaceutical Co., Ltd., 2512-1, Oshikiri, Kohnan-machi, Osato-gun, Saitama 360-0111, Japan; Central Research Laboratories, ZERIA Pharmaceutical Co., Ltd., 2512-1, Oshikiri, Kohnan-machi, Osato-gun, Saitama 360-0111, Japan; Central Research Laboratories, ZERIA Pharmaceutical Co., Ltd., 2512-1, Oshikiri, Kohnan-machi, Osato-gun, Saitama 360-0111, Japan; Central Research Laboratories, ZERIA Pharmaceutical Co., Ltd., 2512-1, Oshikiri, Kohnan-machi, Osato-gun, Saitama 360-0111, Japan; Central Research Laboratories, ZERIA Pharmaceutical Co., Ltd., 2512-1, Oshikiri, Kohnan-machi, Osato-gun, Saitama 360-0111, Japan; Drug Safety Testing Center Co., Ltd., Pharmacological Research Laboratories, 88-75 Shingo, Higashimatsuyama-shi, Saitama 355-0071, Japan; Cerep Inc., 15318 NE 95th Street Redmond, WA 98052-2517, USA; Central Research Laboratories, ZERIA Pharmaceutical Co., Ltd., 2512-1, Oshikiri, Kohnan-machi, Osato-gun, Saitama 360-0111, Japan; (European journal of pharmacology, v.497, 2004, pp.223-231)
QUICK MENU
